Microbiology Cumulative Tests 1–13: Comprehensive Exam Review & Practice Questions

Page
Microbiology
1 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
cummulative10/20/2026Page
test 1-13Page 11ofof2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
cummulative test 1-13.pdf10/20/2026,
cummulative
cummulative
4:09:33 AMtest
test1-13.pdf10/20/2026,
1-13.pdf10/20/2026,4:09:33
4:09:33AM
AM




Drugs that inhibit _____ synthesis are usually the most cell wall
selectively toxic?


Penicillin and Cephalosporins contain a _____ ring? beta-lactam


Which drug is often the "last resort" for MRSA? Vancomycin


Why are fungal infections harder to treat than bacterial Both eukaryotes
ones?


Name one mechanism bacteria use for drug resistance enzymes
efflux pumps


Overgrowth of the normal biota during rx treatment superinfection


The _____ test measures the zone of inhibition to determine kirby bauer
drug susceptibility?


Sum total of all microbes found on a normal human. Microbiome




Page 1 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
Page 1 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
Page 1 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
cummulative test 1-13.pdf10/20/2026,
cummulative test 1-13.pdf10/20/2026,
cummulative
4:09:33 AM test 1-13.pdf10/20/2026,
4:09:33 AM 4:09:33 AM

,Page
Microbiology
2 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
cummulative10/20/2026Page
test 1-13Page 22ofof2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
cummulative test 1-13.pdf10/20/2026,
cummulative
cummulative
4:09:33 AMtest
test1-13.pdf10/20/2026,
1-13.pdf10/20/2026,4:09:33
4:09:33AM
AM




Pathogen that causes infection in a compromised host opportunistic


The minimum # of microbes to cause an infection Infectious dose


3 stages of inflammation? vasodilation, fever, pain


_____ are toxins sevreted by the living bacteria exotoxins


Lipopolysaccaride (LPS) is an example of a _____? Endotoxin


Infection that stays where the pathogen entered local


Microbes multiplying in blood septicemia


What is the difference between a sign & symptom? sign is objetive seen by others
symptom is subjective felt by patient


A permanent record of past infection sequelae


Infection from animal to human zoonosis


Page 2 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
Page 2 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
Page 2 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
cummulative test 1-13.pdf10/20/2026,
cummulative test 1-13.pdf10/20/2026,
cummulative
4:09:33 AM test 1-13.pdf10/20/2026,
4:09:33 AM 4:09:33 AM

, Page
Microbiology
3 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
cummulative10/20/2026Page
test 1-13Page 33ofof2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
cummulative test 1-13.pdf10/20/2026,
cummulative
cummulative
4:09:33 AMtest
test1-13.pdf10/20/2026,
1-13.pdf10/20/2026,4:09:33
4:09:33AM
AM




List 4 stages of clinical infection incubation
prodromal
invastion
convalesent


A _____ carrier is infected but shows no symptoms asymptomic


Inanimate object that spreads disease fomite


Study of disease in a population epidemiology


A disease notifiable that must be reported reportable


Disease constantly present in a population is a _____ endemic
disease


Primary habitat from which a pathogen originates? reservoir


Severity of disease virulence


Sites through which pathogens enter the body portals of entry

Page 3 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
Page 3 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
Page 3 of 2410/20/2026https://www.stuvia.com/user/????????????????????"OP@)(@)(*#@(#*@#&*$^&)(*@)$*$(&(Y&*&%Y&*(@)&$(&%*&%*&(&%@&*($#(*&98oMicrobiology
cummulative test 1-13.pdf10/20/2026,
cummulative test 1-13.pdf10/20/2026,
cummulative
4:09:33 AM test 1-13.pdf10/20/2026,
4:09:33 AM 4:09:33 AM